New autoantibodies in pediatric opsoclonus myoclonus syndrome - PubMed (original) (raw)
New autoantibodies in pediatric opsoclonus myoclonus syndrome
A Kirsten et al. Ann N Y Acad Sci. 2007 Sep.
Abstract
Opsoclonus-myoclonus syndrome (OMS) is a rare neurologic disorder comprising the main symptoms of eye-movement disturbances, muscle jerks, and severe ataxia. In children and adults, some cases are associated with a tumor as a paraneoplastic syndrome, whereas in children the paraneoplastic form is almost exclusively associated with neuroblastoma. The detection of autoantibodies in some OMS sera led to the hypothesis that the syndrome is of autoimmune origin. Beside autoantibodies against intracellular proteins, such as anti-Hu, alpha-enolase, and KHSRP, specific binding of autoantibodies to the surface of neuroblastoma cells and cerebellar granular neurons have been found. Antiproliferative and proapoptotic effects of these autoantibodies on neuroblastoma cell lines were noted as well. These results support the concept of a humoral autoimmune process in the pathogenesis of OMS.
Similar articles
- Identification of autoantigens in pediatric opsoclonus-myoclonus syndrome.
Blaes F, Fühlhuber V, Preissner KT. Blaes F, et al. Expert Rev Clin Immunol. 2007 Nov;3(6):975-82. doi: 10.1586/1744666X.3.6.975. Expert Rev Clin Immunol. 2007. PMID: 20477144 - IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Beck S, Fühlhuber V, Krasenbrink I, Tschernatsch M, Kneifel N, Kirsten A, Jaeger C, Kaps M, Preissner KT, Lang B, Rostasy K, Blaes F. Beck S, et al. J Neuroimmunol. 2007 Apr;185(1-2):145-9. doi: 10.1016/j.jneuroim.2007.01.006. Epub 2007 Feb 26. J Neuroimmunol. 2007. PMID: 17324472 - Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I, Fühlhuber V, Juhasz-Boess I, Stolz E, Hahn A, Kaps M, Hero B, Blaes F. Krasenbrink I, et al. Neuropediatrics. 2007 Jun;38(3):114-6. doi: 10.1055/s-2007-985906. Neuropediatrics. 2007. PMID: 17985258 - Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
Raffaghello L, Conte M, De Grandis E, Pistoia V. Raffaghello L, et al. Eur J Paediatr Neurol. 2009 May;13(3):219-23. doi: 10.1016/j.ejpn.2008.04.012. Epub 2008 Jun 20. Eur J Paediatr Neurol. 2009. PMID: 18571942 Review. - [Paraneoplastic opsoclonus-myoclonus syndrome--a review].
Matsumoto H, Ugawa Y. Matsumoto H, et al. Brain Nerve. 2010 Apr;62(4):365-9. Brain Nerve. 2010. PMID: 20420176 Review. Japanese.
Cited by
- Opsoclonus myoclonus.
Scarff JR, Iftikhar B, Tatugade A, Choi J, Lippmann S. Scarff JR, et al. Innov Clin Neurosci. 2011 Dec;8(12):29-31. Innov Clin Neurosci. 2011. PMID: 22247816 Free PMC article. - Paraneoplastic neurologic syndromes in children: a review article.
Alavi S. Alavi S. Iran J Child Neurol. 2013 Summer;7(3):6-14. Iran J Child Neurol. 2013. PMID: 24665300 Free PMC article. Review. - Acute Movement Disorders in Childhood.
Garone G, Graziola F, Grasso M, Capuano A. Garone G, et al. J Clin Med. 2021 Jun 17;10(12):2671. doi: 10.3390/jcm10122671. J Clin Med. 2021. PMID: 34204464 Free PMC article. Review. - Movement disorders in paraneoplastic and autoimmune disease.
Panzer J, Dalmau J. Panzer J, et al. Curr Opin Neurol. 2011 Aug;24(4):346-53. doi: 10.1097/WCO.0b013e328347b307. Curr Opin Neurol. 2011. PMID: 21577108 Free PMC article. Review. - Diagnosis and management of paraneoplastic neurologic disorders.
Rosenfeld MR, Dalmau J. Rosenfeld MR, et al. Curr Treat Options Oncol. 2013 Dec;14(4):528-38. doi: 10.1007/s11864-013-0249-1. Curr Treat Options Oncol. 2013. PMID: 23900965 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources